Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-Linked Hypophosphatemia (XLH).

التفاصيل البيبلوغرافية
العنوان: Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-Linked Hypophosphatemia (XLH).
المؤلفون: Ross R; Rush University Medical Center., Carpenter K; Rush University Medical Center., Alkhatib D; Rush University Medical Center., Dulion B; Rush University Medical Center., Guirado E; UIC., Patel S; Rush University Medical Center., Chen Y; University of Illinois Chicago College of Dentistry., George A; Department of Oral Biology.
المصدر: Research square [Res Sq] 2023 Apr 12. Date of Electronic Publication: 2023 Apr 12.
نوع المنشور: Preprint
اللغة: English
بيانات الدورية: Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE
مستخلص: X-linked hypophosphatemia (XLH) is a rare disease of elevated fibroblast growth factor 23 (FGF23) production that leads to hypophosphatemia and poor mineralization of bone and teeth. The clinical manifestations of XLH include a high prevalence of dental abscesses, likely driven by poorly formed structures of the dentoalveolar complex, including the alveolar bone, cementum, dentin, and periodontal ligament. Our previous studies have demonstrated that sclerostin antibody (Scl-Ab) treatment improves phosphate homeostasis, and increases bone mass, strength and mineralization in the Hyp mouse model of XLH. In the current study, we investigated whether Scl-Ab impacts the dentoalveolar structures of Hyp mice. Male and female wild-type and Hyp littermates were injected with 25 mg/kg of vehicle or Scl-Ab twice weekly beginning at 12 weeks of age and euthanized at 20 weeks of age. Scl-Ab increased alveolar bone mass in both male and female mice and alveolar tissue mineral density in the male mice. The positive effects of Scl-Ab were consistent with an increase in the fraction of active (non-phosphorylated) β-catenin stained alveolar osteocytes. Scl-Ab had no effect on mineralized tissues of the tooth - dentin, enamel, acellular and cellular cementum. There was a non-significant trend toward increased periodontal ligament (PDL) attachment fraction within the Hyp mice. Additional PDL fibral structural parameters were not affected by Scl-Ab. The current study demonstrates that Scl-Ab can improve alveolar bone in the Hyp mouse model of XLH.
Competing Interests: Declaration of Conflicting Interests The authors declared no potential conflicts of interest with respect to the research and/or publication of this article.
التعليقات: Update in: Int J Oral Sci. 2023 Oct 10;15(1):47. (PMID: 37813865)
معلومات مُعتمدة: K01 AR073923 United States AR NIAMS NIH HHS; R01 DE031737 United States DE NIDCR NIH HHS; R03 DE029873 United States DE NIDCR NIH HHS
فهرسة مساهمة: Keywords: Rickets; hypophosphatemia; mineralized tissue/development; osteomalacia; periodontium
تواريخ الأحداث: Date Created: 20230424 Latest Revision: 20240503
رمز التحديث: 20240503
مُعرف محوري في PubMed: PMC10120757
DOI: 10.21203/rs.3.rs-2762671/v1
PMID: 37090634
قاعدة البيانات: MEDLINE
الوصف
DOI:10.21203/rs.3.rs-2762671/v1